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ABSTRACT
INTERMITTENT SWIM STRESS EFFECTS ON ANXIETY BEHAVIOR
Timothy A. Warner 
University of New Hampshire May 2013 
Millions of Americans are suffering from depression each year, leading to 
a significant number of individuals who seek treatment for their ailment.
However, fewer than 50 percent of depressed individuals fully recover using 
current methods. The comorbidity between depression and anxiety could be a 
contributing factor in the lower rates of recovery. The demonstrated correlation 
between anxiety and depression has led to the term “anxious depression,” which 
is associated with difficulty in coping, a poorer rate of recovery, and more severe 
symptoms of depression. The purpose of this dissertation was to expand on an 
existing animal model of depression (intermittent swim stress) and its possible 
relationship to anxiety. In the intermittent swim stress (ISS) model, animals 
experienced 100, 5 second trials of cold water swim stress, and subsequent 
behavioral and cellular mechanisms were assessed. Behavioral measures 
incorporated animal models of anxiety (i.e., open field test and juvenile social 
exploration), while serotonergic and noradrenergic neurons were assessed at the 
dorsal raphe nucleus and locus coeruleus, respectively, through 
immunohistochemistry techniques. Results indicated ISS-induced deficits were 
noted for social exploration, but not with the open field test. No apparent cellular
differences were revealed following the open field test, but this has yet to be 
investigated for juvenile social exploration. The anxiety effects produced by ISS 
support the trans-situational value of the model and also suggest ISS as a 
possible animal model of post-traumatic stress disorder. Future directions should 
assess cellular mechanisms following exposure to juvenile social exploration as 




Stress is affiliated with a variety of psychological conditions. In particular, 
stress is a common risk factor for depression and anxiety (Lapiz-Bluhm, Bondi, 
Doyen, Rodriguez, Be'dard-Arana, and Morilak, 2008; Revollo, Qureshi, 
Collazos, Valero, & Casas, 2011). Depression is a debilitating disorder that 
anyone can experience. An estimated 35 to 40 million Americans, or 
approximately 17.6 million Americans each year (Knol, Twisk, Beekman, Heine, 
Snoek, & Pouwer, 2006), will suffer from severe depression at some point during 
their lives (Kathryn, 2011; Weissmanm & Klerman, 1978). It is anticipated that 
this number will continue to climb, as depression is projected to be the second 
most disabling condition in the world by 2020 (Mathers, Fat, & Boerma, 2008). 
This expectation could be due to the fact that depression has a strong 
association with anxiety. The demonstrated correlation between anxiety and 
depression has led to the term “anxious depression” (Fava, Rosenbaum, Hoog, 
Tepner, Kopp, & Nilsson, 2000; Fava, Rush, Alpert, Balasubramani, Wisniewski, 
Carmin, et al., 2008; Fava, Uebelacker, Alpert, Nierenberg, Pava, & Rosenbaum, 
1997; Simon, 2009; Van Valkenburg, Akiskal, Puzantian, & Rosenthal, 1984). 
Anxious depression is correlated with difficulty in coping, a poorer rate of 
recovery (Nelson, 2008), more severe symptoms of depression (Silverstone &
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Salinas, 2001), but, in terms of the rate of relapse, anxious depression is similar 
to that of depressed patients without anxiety (Flint & Rifat, 1997).
Fewer than 50 percent of depressed patients experience a complete 
recovery using the current treatment methods (Berton & Nestler, 2006). This 
lack of effective treatment options is burdensome not only to those who suffer 
from depression, but also to those who must care for them (Mathers, Fat, & 
Boerma, 2008). As a result, it is critical to have a further understanding of the 
neural substrates involved in the comorbidity of depression and anxiety. 
Depression
Symptoms. According to the American Psychiatric Association (2000), 
major depression is a psychiatric disorder characterized by: depressed mood; 
loss of interest in activities; significant change in weight; difficulty sleeping or 
thinking; restless activity; low energy; feelings of worthlessness, hopelessness, 
or guilt; and recurrent thoughts of death or suicide. These symptoms may be 
similar to other psychiatric disorders (e.g., anxiety disorders, bipolar disorder, 
and post-traumatic stress disorder). However, major depression can only be 
classified as such when several of the above symptoms are persistent for two 
weeks or longer, disrupt daily social- or work-related activities, and cannot be 
attributed to other causes (e.g., medical conditions such as hypothyroidism) or 
disorders. Depression is a common disorder that anyone could be susceptible 
to, but people with family members suffering from depression are at a greater risk 
of development. The genetic risk is approximately 40-50 percent greater than 
people with no family history of depression (Fava & Kendler, 2000; Weissman,
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Wickramaratne, Nomura, Warner, Verdeli, Pilowsky, et al., 2005). Additionally, 
environmental factors, such as some form of trauma, disease, or life stress, can 
contribute to depression (Fava & Kendler, 2000; Nestler, Barrot, DiLeone, Eisch, 
Gold, & Monteggia, 2002); and, in general, women tend to be at a greater risk of 
depression (Kessler, McGonagle, Swartz, Blazer, & Nelson, 1993; Wade, 
Caimey, & Pevalin, 2002).
Relation to Anxiety. There is a noticeable relationship between 
depression and anxiety, as depression is often experienced by anxiety patients 
and vice versa. In fact, 62 percent of patients suffering from major depression 
also have high levels of anxiety (Boehnlein & Kinzie, 2007). Ultimately, anxiety 
and depression share several symptoms such as sleep problems (Eller, Aluoja, 
Vasar, & Veldi, 2006), feelings of worthlessness, and cognitive impairments to 
name a few —  with stress as a common risk factor (Lapiz-Bluhm et al., 2008). 
This overlap between anxiety and depression is the result of similarities between 
neurobiological mechanisms, and the fact that both may respond to the same 
pharmacological treatments (i.e., serotonin- and norepinephrine-based drugs; 
Nutt, Ballenger, Sheehan, & Wittchen, 2002).
Neuropsychology of Anxiety. Gray (1982) initially outlined the idea of the 
“neuropsychology of anxiety.” The neural and behavioral effects of anxiolytic 
drugs in animals can translate to the anxiety experienced by humans. The 
behavioral actions of anxiolytic drugs can be depicted through the behavioral 
inhibition system. The primary role of the behavioral inhibition system is to 
assess risk and increase risk aversion when situations of conflict present
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themselves through a comparator, which compares actual and expected stimuli, 
known as the septo-hippocampal system. A conflict may be generated through 
signals of punishment, signals of non-reward, or novel or fearful stimuli.
However, the behavioral inhibition system is implemented for resolution of the 
conflict to avoid negative or painful outcomes. The septo-hippocampal system is 
believed to encode various facets of anxiety. When there is a failure to handle 
an expected conflict (e.g., an unpredictable or fearful event) this system will 
activate the amygdala to produce a state of anxiety and increase avoidance 
tendencies. The administration of anxiolytics can help to resolve the conflict by 
modulating behavioral inhibition induced by fear, increasing arousal, and 
increasing attention. The septo-hippocampal system is indeed a vital component 
of the behavioral inhibition system, as anxiolytics impair the control of theta 
activity, the principle response to arousal, in the hippocampus. More importantly, 
a lesion to the septal or hippocampal regions leads to a significant reduction in 
functioning of the behavioral inhibition system (McNaughton & Gray, 2000).
Neurobioloaical Basis of Anxiety. In terms of the neurological aspects of 
anxiety, research has primarily focused on GABAergic, serotonergic, and 
noradrenergic neurotransmitter systems playing the most critical roles for 
anxiety-related disorders. GABAergic neurons, specifically GABAa receptors, are 
widely distributed throughout the brain and are believed to regulate anxiety/fear 
responses by inhibiting both the locus coeruleus and raphe nucleus —  thereby 
suppressing neuronal firing. The locus coeruleus and raphe nucleus are where 
the majority of noradrenergic and serotonergic neurons are located, respectively.
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Due to its inhibitory effects, GABA (gamma-aminobutyric acid) acts as a 
moderator by suppressing neuronal firing in the locus coeruleus and raphe 
nucleus (Dell’Osso, Buoli, Baldwin, & Altamura, 2010).
The noradrenergic neurons in the locus coeruleus project to the forebrain. 
Their role in anxiety could also be associated with their connection to stress, 
arousal, and fear (Aston-Jones & Cohen, 2005; Aston-Jones, Rajkowski, Kubiak, 
Valentino, & Shipley, 1996; Bremner, Kristal, Southwick, & Charney, 1996).
When there is an increase in the production and release of norepinephrine, there 
is an elevation in anxiety levels. On the other hand, when neuronal firing in the 
locus coeruleus is depleted (Grimsley, 1995) or lesioned (Redmond, 1977; 
Redmond, Huang, Synder, & Maas, 1976), there is a significant reduction in 
anxiety-fear behavior. As for the serotonergic neurons in the raphe nucleus, 
there is a projection to areas throughout the brain such as the limbic system, 
hypothalamus, and bed nucleus of stria terminalis (BNST). Moreover, when 
there are elevated levels of serotonin, there is also a greater incidence for 
anxiety-related disorders (Dell’Osso, Buoli, Baldwin, & Altamura, 2010), and the 
serotonergic neurons of the dorsal raphe nucleus (DRN) are known to act as 
mediators in stressful situations. In fact, the DRN-BNST pathway is suggested to 
be important in mediating anxiety-related behaviors (Commons, Connolley & 
Valentino, 2003; Phelix, Liposits & Pauli, 1992).
Corticotropin-releasing factor (CRF) acts as a physiological mediator of 
stress-related functions (Hammack, Richey, Schmid, LoPresti, Watkins, & Maier, 
2002; Hammack, Schmid, LoPresti, Der-Avakian, Pellymounter, Foster, et al.,
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2003; Price, Kirby, Valentino, & Lucki, 2002; Mo, Feng, Renner, & Forster, 2008; 
Rivier & Vale, 1983), as intracerebral administration of CRF yields similar results 
produced by stressors (Koob & Heinrichs, 1999). Moreover, blocking the CRF 
receptors greatly attenuates the release of serotonin during the stress response 
(Hammack et al., 2002, 2003; Price & Lucki, 2001; Mo et al., 2008), and reduces 
anxiety behaviors (Deak, Nguyen, Ehriich, Watkins, Spencer, Maier, et al., 1999; 
Ising & Holsboer, 2007; Risbrough & Stein, 2006). This is an interesting notion, 
because the DRN receives extensive projections from the CRF neurons 
(Sakanak, Shibasaki, & Lederis, 1987). As a result, areas containing CRF 
receptors have been correlated with anxiety. CRF has two receptor subtypes: 
CRF type 1 receptor (CRFi) and CRF type 2 receptor (CRF2). CRF1 receptors 
are mostly located in the amygdala, BNST, cerebral cortex, and brainstem, while 
CRF2 receptors can be found mostly in the amygdala, BNST, lateral septum, and 
ventromedial hypothalamus (Chen, Brunson, Muller, Cariaga, & Baram, 2000; 
Van Pett, Viau, Bittencourt, Chan, Li, Arias, et al., 2000). The following will 
expand more on the roles of serotonin and norepinephrine as well as the brain 
areas involved for anxiety/depression.
Serotonin & Neural Innervations. The role of serotonin (5- 
hydroxytryptamine, 5-HT) in anxiety is complex, as it has various receptor 
subtypes, which can be located on either the presynaptic or postsynaptic 
membranes. These receptors can yield excitatory or inhibitory effects (Hoyer, 
Hannon, & Martin, 2002), which is also true of other monoamines (Knapp, 
Breese, Mueller, & Breese, 2001). Electrical stimulation of the dorsal
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periaqueductal gray (DPAG) area induces anxious behavior, but stimulation of 5- 
HTia or 5 -HT2A presynaptic autoreceptors in the DPAG reduces anxiety. This 
suggests that the 5-HT nerve fibers in the DPAG may regulate anxiety behavior 
(Graeff, 2002). The 5-HT receptor subtypes in the DPAG may have unique 
characteristics, as genetic studies with rodents noted that the inactivation of 5- 
HTia (Gross, Zhuang, Stark, Ramboz, Oosting, Kirby, et al., 2002) and 5-HT2a 
(Weisstaub, Zhou, Lira, Lambe, Gonzalez-Maeso, Hornung et al., 2006) 
postsynaptic receptors led to increased or decreased anxiety, respectively. 
Additionally, when 5-HTiA receptors are active in the dentate gyrus of the 
hippocampus there is a decrease of anxiety behavior (Tsetsenis, Ma, Lacono, 
Beck, & Gross et al., 2007).
With regard to other brain areas associated with 5-HT, the basolateral 
amygdala receives serotonergic innervation from the DRN (Hale et al., 2008a; 
Fallow & Ciofi, 1992). Furthermore, there is noticeable activation of the 
basolateral amygdala when subjected to an anxiety-provoking stimulus (Hale et 
al., 2008a; Hale, Hay-Schmidt, Mikkelsen, Poulsen, Shekhar, & Lowry, 2008b). 
There is also activation of the 5-HT neurons in the DRN, a significant source of 
production of 5-HT in the brain, following anxiogenic or stressful stimuli derived 
from drug-induced anxiety (Christianson et al., 2008a) or uncontrollable stress 
(Grahn, Will, Hammack, Maswood, McQueen, Watkins, et al., 1999).
5-HT neurons in the DRN are sensitive to pharmacological compounds. 
The administration of anxiogenic compounds such as p-carbolines (Christianson, 
Paul, Irani, Thompson, Kubala, Yirmiya, et al., 2008a; Abrams, Johnson, Hay-
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Schmidt, Mikkelsen, Shekhar, & Lowry, 2005) that bind to 5 -HT2A/2C receptors 
(Grella, Teitler, Smith, Herrick-Davis, & Glennona, 2003), inverse 
benzodiazepine agonists (Maier, Busch, Maswood, Grahn, & Watkins, 1995a), 5- 
HT2A/2C receptor agonists, and even caffeine administration are associated with 
enhanced anxiety levels (Abrams et al., 2005). Whereas, anxiolytics such as 5- 
HTia agonists have been associated with attenuating anxiety levels (Christianson 
et al., 2008a). 5-H T ia agonists such as 8-hydroxy-2-(di-n-propylamino)tetralin (8- 
OH-DPAT), ipsapirone, gepirone, and buspirone work by inhibiting the neuronal 
firing of the DRN (Fornal, Litto, Metzler, Marrosu, Tada, & Jacobs, 1994), which 
result in the anxiolytic responses (Blier, Pineyro, Dennis, & DeMontigny, 1993).
The activation of the 5-HT neurons in the DRN from an uncontrollable 
stressor (e.g., inescapable shock) increases 5-HT levels in the DRN (Maswood, 
Barter, Watkins, & Maier, 1998), and also sensitizes these neurons for 24-72 
hours. Later stimulation of the 5-HT neurons during further behavioral testing 
creates an exaggerated amount of 5-HT that is released in the DRN projection 
regions (e.g., areas associated with the limbic system; Amat, Matus-Amat, 
Watkins, & Maier, 1998). Inescapable shock (an uncontrollable stressor) seems 
to activate the DRN 5-HT neurons to a greater degree than escapable shock (a 
controllable stressor) in four ways:1 DRN lesions (Maier, Grahn, Kalman, Sutton, 
Wiertelak, & Watkins, 1993) or otherwise inhibiting the activation of the DRN 
(Maier, Grahn, & Watkins, 1995b) prevent inescapable shock-induced deficits,2 
Blocking 5 -HT2C receptors in projection regions of the DRN (Christianson,
Ragole, Amat, Greenwood, Strong, Paul, et al., 2010) prevent inescapable
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shock-induced deficits, and3 In the absence of any inescapable shock exposure, 
pharmacological activation (via p-carbolines) of the DRN 5-HT neurons induces 
inescapable shock deficits (Maier et al., 1995a), and4 DRN lesions block the 
effects of anxiogenic drugs such as p-carbolines (Hindley, Hobbs, Paterson, & 
Roberts, 1985; Maier et al., 1995a). However, the DRN does not appear to be 
associated with the process of stress controllability or coping. Controllability 
(escapable shock) is believed to be regulated by the ventromedial prefrontal 
cortex (vmPFC; Amat, Baratta, Paul, Bland, Watkins, & Maier, 2005).
When the vmPFC is activated or inactivated during inescapable shock, it 
either prevents or facilitates, respectively, inescapable shock-induced deficits.
The above observations indicate that the activation of the vmPFC is critical for 
the protective effects of controllability of electric shock (Amat et al., 2005; Amat, 
Paul, Watkins, & Maier, 2008). Furthermore, vmPFC plays a significant role in 
regulating the activity of the amygdala, a brain area known for emotion regulation 
such as anxiety (Jovanovic & Ressler, 2010). For people suffering from an 
anxiety disorder, such as post-traumatic stress disorder, higher levels of activity 
in the vmPFC correlate to higher levels of anxiety (Koenigs et al., 2008). In 
general, there appears to be mixed results for the role of the vmPFC with regard 
to the stress response (i.e., glucocorticoid release), as activity in the vmPFC has 
been shown to inhibit as well as enhance glucocorticoid release (Myers-Schulz & 
Koenigs, 2011), which could be due to the prelimbic and infralimbic subregions of 
the vmPFC (Baratta, Zarza, Gomez, Campeau, Watkins, & Maier, 2009).
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Norepinephrine & Neural Innervations. Norepinephrine also plays a 
significant role in anxiety, as noradrenergic neurons in the LC project to a variety 
of areas throughout the brain (e.g., cerebellum, hypothalamus, amygdala, 
hippocampus, prefrontal cortex; Bishop, 2007). Exposure to different stressors 
(e.g., electric shock or conditioned fear) results in increased production of 
norepinephrine in the LC (Pacak & Palkovits, 2001), but activity in the LC does 
not appear to be dependent upon stressor controllability (McDevitt et al., 2009). 
Stress exposure also results in norepinephrine increases in the amygdala, 
hippocampus, and hypothalamus (specifically in the paraventricular nucleus; 
Pacak & Palkovits, 2001). The increase of norepinephrine in the paraventricular 
nucleus of the hypothalamus activates the sympathetic nervous system and the 
hypothalamic-pituitary-adrenal (HPA) axis. This increases the release of 
glucocorticoids and adrenalin (or epinephrine), which can also result in increased 
anxiety behaviors (Koob, 1999).
Electrical stimulation of the LC induces anxiety, while lesioning this region 
prevents anxiety symptoms (Redmond, 1977; Redmond, Huang, Synder, & 
Maas, 1976). Within the LC, norepinephrine effects tend to be mediated through 
the presynaptic alpha-2 receptors and postsynaptic alpha-1 and beta-1 receptors. 
When targeting the alpha-2 autoreceptor via an alpha-2 adrenergic antagonist, 
yohimbine, there is an increase in production in norepinephrine from the LC.
This, in turn, facilitates symptoms of anxiety (Grimsley, 1995). However, an 
alpha-2 adrenergic agonist, clonidine, has been shown to inhibit functioning of 
the LC with the dose playing a vital role. These effects tend to be caused by
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lower doses acting on presynaptic (alpha-2) autoreceptors (Solanto, 1998), and 
the diminished production of norepinephrine will thereby attenuate anxiety levels 
(Grimsley, 1995). Higher doses of clonidine are believed to act on postsynaptic 
receptors, are ineffective at inhibiting norepinephrine, and actually foster the 
release of norepinephrine (Ramos and Arnsten, 2007).
Traumatic stress such as some anxiety disorders (i.e., post-traumatic 
stress disorder) results in an exaggerated production and release of 
norepinephrine (Strawn & Geracioti, 2008). However, depression is not directly 
caused by either an increase or decrease of norepinephrine in the brain, as 
norepinephrine’s more critical role is to act as a moderator for major inhibitory or 
excitatory neurotransmitters (e.g., gamma-aminobutyric acid and glutamate; 
Anand & Chamey, 2007).
Serotonin & Norepinephrine Interaction. 5-HT and norepinephrine have a 
significant relationship with each other, as 5-HT projects to norepinephrine 
neurons and vice versa. Moreover, the projections of 5-HT neurons to 
norepinephrine neurons appear to be inhibitory. When there is a significant 
lesion of 5-HT neurons, the firing rate of norepinephrine neurons increase to 
approximately 70 percent above baseline in the locus coeruleus (Dremencov, El 
Mansari, & Blier, 2007). 5-HT’s inhibitory nature on norepinephrine is further 
confirmed by depleting the availability of norepinephrine and administering 
selective-serotonin reuptake inhibitors (SSRIs). Inhibition of norepinephrine 
neurons via systemic administration substantially diminishes the rate of neuronal 
discharge for 5-HT in the DRN for the first few days (Svensson, Bunney, &
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Aghajanian, 1975). Prolonged exposure to SSRI treatment has demonstrated a 
considerable decrease in the firing rate from norepinephrine neurons over a 
longer period of time (Blier, 2001).
Mirtazapine, which provides treatment for anxiety and depression, acts as 
an antagonist at both the 5-HT2a/2c and norepinephrine alpha-2 receptors 
(Kooyman, Zwart, Vanderheijden, Van Hooft, & Vijverberg, 1994; Millan, Gobert, 
Rivet, Adhumeau-Auclair, Cussac, Newman-Tancredi, et al., 2000). Chronic 
treatment with mirtazapine will cause an increase in the production of both 5-HT 
and norepinephrine; a smaller increase for norepinephrine and a more prominent 
increase for 5-HT, However, when the norepinephrine neurons are lesioned in 
the LC, the increase in the 5-HT activity produced by mirtazapine is no longer 
apparent (Blier, 2001). Furthermore, projections of norepinephrine neurons to 5- 
HT neurons tend to enhance the regeneration of serotonergic axons (Liu & 
Nakamura, 2006) suggesting an excitatory pathway. Ressler and Nemeroff 
(2000) have even suggested that there are both excitatory and inhibitory 
projections from the LC to DRN.
When selecting an antidepressant drug, for treatment of depression or an 
anxiety disorder, it is important to understand the functioning of both the 5-HT 
and norepinephrine systems. The effectiveness of antidepressants is thought to 
be due to a prolonged increase in the availability of the neurotransmitter at the 
synapse, which will decrease the number of receptors on the postsynaptic 
terminal (also known as down-regulation; Norman, 1999), as well as increases in 
brain-derived neurotrophic factor (BDNF) expressions and subsequent
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neurogenesis in the brain (Jacobs, van Praag, & Gage, 2000; Malberg, Eisch, 
Nestler, & Duman, 2000). Additionally, in terms of more effective therapeutic 
treatment, if there is a deficiency in one neural system (i.e., 5-HT or 
norepinephrine) at times it may be more beneficial to treat the other system to 
reach the desired end result. In fact, depression that is associated with 5-HT 
depletion can be alleviated by enhancing the availability of norepinephrine. The 
cause of depression is far more complex than just focusing on the fluctuations of 
only 5-HT or norepinephrine levels. Dysfunctions in the brain associated with 
depression as well as anxiety disorders are likely modulated by different 
monoamine systems (Delgado, 2006; Delgado & Moreno, 2000). In an effort to 
investigate 5-HT or norepinephrine changes, in particular anatomical regions 
following exposure to a stressful stimulus, a variety of methods have been 
implemented (e.g., micro dialysis, autoradiography, or c-Fos). However, c-Fos is 
ideal because it allows an isolation of an anatomical area of interest.
c-Fos Immunohistochemistrv. c-Fos is the protein product of an 
immediate early gene, and is a marker of neuronal activation. Following 
exposure to anxiogenic (e.g., p-carboline) or stressful stimuli, c-Fos is expressed 
in the DPAG (Lino-de-Oliveira, de Oliveira, Padua Carobrez, de Lima, del Bel, & 
Guimaraes, 2006), basolateral amygdala (Knapska, Radwanska, Werka, & 
Kaczmarek, 2007), DRN (Amat et al., 2005), prelimbic and infralimbic 
subregions of the vmPFC (Baratta et al., 2009), and LC (Webb, Patton, Landry, 
Mistlberger, 2010). The double-immunostaining protocol for c-Fos is an ideal 
technique for identifying which class of neurons is active, thereby allowing us to
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investigate the 5-HT and norepinephrine systems. It is advantageous because it 
can provide greater clarity to different aspects of the cell (i.e., shape, size, and 
orientation of dendrites), which is not possible using the nuclear, Fos 
immunoreactivity technique (Peng, Chen, & Bentivoglio, 1995).
Animal Models of Depression
Use of Animal Models. Animal models are critical to understanding the 
various components of depression and to allow insight into novel drug discovery. 
Pre-clinical experiments allow researchers to have complete control over the 
experimental parameters of the subject (e.g., age, experiential history, sex, 
weight, food-intake, and environment), which can be quite difficult to accomplish 
in human models. Additionally, animal models have the potential to provide 
ground-breaking results, and can establish unequivocal cause-and-effect 
relationships. While research has been conducted on a variety of animals, rats 
have been a reliable and extensively used subject. The rat is an ideal animal 
specimen because its anatomical and physiological features parallel those of 
humans. However, one might wonder how depression can be elicited and 
objectively measured in animals?
Experimentally simulating depression has been discussed in great detail, 
as various authors have considered the advantages and disadvantages of animal 
models (Cryan, Markou, & Lucki, 2002; Henn, Edwards, & Muneyyirci, 1993; 
Porsolt, 2000). Ultimately, most authors accept a set of criteria devised by 
Mckinney and Bunney (1969). These guidelines indicate that the animal model 
includes: comparable symptoms to those experienced by humans; behavioral
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endpoints that can be measured in an objective manner; induced depression to 
be remedied by treatments that could potentially be effective for humans (e.g., 
antidepressants); and procedures and results that can be replicated by other 
researchers.
A limitation of animal models is that it is difficult to examine all of the 
symptoms identified by the American Psychiatric Association (2000) in the 
diagnostic criteria of major depression. In particular, symptoms such as 
depressed mood, feelings of worthlessness, hopelessness, or guilt, and recurrent 
thoughts of death or suicide are impossible to evaluate —  researchers cannot 
access what the animal is thinking during behavioral testing. However, through 
behavioral endpoints, it is possible to monitor other depressive behaviors such as 
anhedonia or low energy, significant change in weight, difficulty sleeping, 
cognitive impairments, social interaction deficits, and restless activity.
Forced-swim test. One of the most widely used models for screening 
novel antidepressants is the forced-swim test (FST), also known as the 
behavioral despair test (Porsolt et al., 1977). In this model, rats are placed in a 
cylinder filled with water. The rat is unable to make contact with the bottom of the 
cylinder with its feet (Borsini, Volterra, & Meli, 1986; Drugan, Skolnick, Paul, & 
Crawley, 1989), which forces the animal to swim. The rat swims in the apparatus 
for 15 minutes during the first session, and then 24 hours later the rat is forced to 
swim again for only 5 minutes. During the time spent in the cylinder on the 
second day, three distinct patterns of behavior are noted by the animal in the 
modified FST (Detke et al., 1995): swimming, climbing, and immobility (floating).
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The behavioral pattern of immobility is of greatest interest, as this is a sign of 
behavioral depression in the animal. Researchers have questioned whether the 
rat is truly experiencing depression when the rat is immobile. Some tend to 
believe the immobile behavior expressed by the rat is rather a “functionally 
adaptive strategy” to cope with the inescapable stressor (Nishimura, Tsuda, 
Oguchi, Ida, & Tanaka, 1988). However, when rats are administered 
antidepressants they emerge from the immobile state to an active state of 
increased swimming or climbing based on the type of antidepressant given 
(Christianson, Rabbett, Lyckland, & Drugan, 2008; Detke, Rickels, & Lucki, 1995; 
Drugan, Macomber, & Warner, 2010; Lucki, 1997). Moreover, antidepressant 
drugs reverse immobility in rats selectively bred for low activity in the swim test 
(Weiss, Cierpial, & West, 1998; West & Weiss, 1998). The effect is not a result 
of general activation, as antidepressant-treated rats subsequently placed in an 
open field test do not show hyperactivity (Porsolt, Anton, Blavet, & Jalfre, 1978).
Learned Helplessness. Another widely used model of depression is that 
of inescapable shock/learned helplessness (Maier & Seligman, 1976; Henn et al., 
1993; Weiss, Goodman, Losito, Corrigan, Charry, & Bailey, 1981). This 
phenomenon was first demonstrated with dogs exposed to inescapable electric 
shocks. The shocks interfered with the dogs’ ability to escape in a shuttle-box 
task (Overmier & Seligman, 1967; Seligman & Maier, 1967). Soon after, 
researchers began testing the effects of learned helplessness on rats and noting 
similar results (Maier, Albin, & Testa, 1973; Weiss & Glazer, 1975). Although 
learned helplessness has been examined in numerous different species, the
16
process of its examination has remained largely consistent. The typical format 
for investigating this concept includes three animals that will be used at a time, 
following a triadic design, with two of the three animals receiving intermittent 
electric shocks and the third serving as the restrained control (therefore receiving 
no shock). Of the two animals being shocked, one animal has the opportunity to 
terminate the shock (escape), for both itself and the yoked-inescapable shock 
subject; typically accomplished by the animal pressing a lever or turning a wheel. 
The other animal will be shocked regardless of its actions (yoked), and thus, the 
highly stressful scenario of inescapable shock is created. After being exposed to 
inescapable shock, research has demonstrated that the animal does not attempt 
to avoid or escape the shocks if given the opportunity to escape. This behavioral 
outcome is indicative of that animal experiencing “learned helplessness” (Maier & 
Seligman, 1976). Animals exposed to inescapable, but not escapable, shock 
have exhibited other behavioral and physiological changes in addition to 
behavioral depression, including: “freezing behavior,” which is an expression of 
fear (Maier, 1990), opioid-mediated stress-induced analgesia (Drugan, Ader, & 
Maier, 1985), anorexia (Dess, Choe, & Minor, 1998), learning deficits (Seligman 
& Maier, 1967), lower activity levels (Desan, Silbert, & Maier, 1988; Drugan & 
Maier, 1983), reduced food competition dominance (Rapaport & Maier, 1978), 
changes in conditioned place preference for drugs of abuse (Rozeske, Der- 
Avakian, Bland, Beckley, Watkins, & Maier, 2009), and anhedonia (Dess, Minor, 
& Brewer, 1989).
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Learned helplessness may result from serotonergic activation (Amat et al.,
1998) and noradrenergic inactivation. Specifically, in the dorsal raphe nucleus 
(Amat, Tamblyn, Paul, Bland, Amat, Foster, et al., 2004; Grahn et al., 1999;
Maier and Watkins, 2005) and the locus coeruleus, respectively, as inescapable 
shock produces large increases in 5-HT (Amat et al., 1998) and decreases in 
norepinephrine (Weiss & Simson, 1986). Animals that are able to cope with the 
effects of stress (escape from the shock) do not display depleted levels of 
norepinephrine (Weiss et al., 1970; Weiss et al., 1981), nor do they show the 
sensitization of the DRN (Rozeske, Evans, Frank, Watkins, Lowry, & Maier,
2011) in comparison to yoked rats. On a pharmacological level, drugs that 
enhance the release of norepinephrine combat the effect of learned helplessness 
(Sherman et al., 1982), while drugs that actively deplete levels of norepinephrine 
produce many behavioral deficits comparable to learned helplessness (Anisman, 
Remington, & Sklar, 1979). Other studies have produced similar results when 
norepinephrine levels were enhanced (Petty, Kramer, Wilson, & Chae, 1993; 
Sherman & Petty, 1980). In terms of the role of 5-HT-based drugs, the 
administration of a 5-HT agonist in the DRN blocks the effects of inescapable 
shock (Maier et al., 1995b).
Intermittent Swim Stress (ISSL ISS has a component of learned 
helplessness, as it uses intermittent, inescapable stress exposure, and also a 
component of behavioral despair (or FST) by using water as the stressor. Water 
is a predominant part of the environment for many animals, and is a naturally 
occurring stressor for rats in comparison to the shock or restraint stress
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mentioned previously (Russell, Towns, Anderson, & Clout, 2005). ISS is an 
effective stressor to induce behavioral depression such as enhanced immobility 
in the FST, interference with instrumental swim escape performance 
(Christianson & Drugan, 2005; Christianson et al., 2008b; Drugan, Macomber, & 
Warner, 2010), as well as increased latency to escape in the Morris water maze 
(MWM; Warner & Drugan, 2012). Unlike inescapable shock and continuous 
swim stress, or stressors that are sensitive to both acute SSRIs and 
norepinephrine selective reuptake inhibitors (NSRIs; Detke et al.,1995; Drugan et 
al., 2010; Maier & Watkins, 2005), ISS effects are sensitive to NSRI yet resistant 
to a variety of serotonergic manipulations —  including SSRIs (Christianson et al., 
2008b; Drugan et al., 2010). This difference suggests that the ISS effects are 
mediated by distinct neural systems that may lead to new insights into stress- 
related pathology and hasten novel drug discovery.
Resemine-lnduced Depression. This is considered as a pharmacological- 
based animal model of depression. Of the various pharmacological agents, the 
administration of reserpine, in particular, elicits signs of depression due to its 
depletion of monoamines. The importance of monoamines can be explained by 
the monoamine hypothesis, which is a controversial idea that depression is the 
result of the underactivity of the monoamines in the brain (Baumeister, Hawkins, 
& Uzelac, 2003).
Olfactory Bulbectomv. For this animal model, the olfactory bulb is 
surgically removed. While it is not clear how this procedure translates to 
depression, it has been suggested that the chronic sensory disruption
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experienced by the animals can act as an intense, stressful experience (O’Neil & 
Moore, 2003)
Congenital Learned Helplessness. This is a genetic animal model of 
depression that incorporates selective breeding. In this model, rats are bred to 
be more or less prone to the effects of learned helplessness, (i.e., shuttlebox 
escape deficits) and thereby creating two categories of rats: congenitally learned 
helplessness and congenitally not learned helpless. For the congenital learned 
helpless group, these rats express a helpless phenotype even during escapable 
shock. For the non-congenital group, this strain of rats is resistant to the effects 
of learned helplessness even during inescapable shock (Henn & Vollmayr, 
2005).
Flinders Sensitive Line Rats. Another genetic animal model of 
depression, these rats are selectively bred to be more sensitive to cholinergic 
agonists (acetylcholine). This paradigm parallels the cholinergic hypersensitivity 
experienced by depressed patients (Overstreet, Friedman, Mathe, & Yadid, 
2005) who experience a heightened sensitivity to cholinergic agonists compared 
to normal controls (Janowsky, Overstreet, & Numberger, 1994; Risch, Kalin, & 
Janowsky, 1981).
Animal Models of Anxiety
In pre-clinical models of anxiety, the goal is to mirror the same symptoms, 
behavioral responses, biological mechanisms, and response to pharmacological 
treatments to those of human anxiety (Ramos, 2008). While there are genetic 
strains of anxious rats such as the Maudsley reactive rat (Broadhurst, 1960),
20
research predominately focuses on conditioned and unconditioned animal 
models of anxiety. Described below are samples of such models.
Conditioned Animal Models of Anxiety
Fear-Potentiated Startle. In this model, an animal will associate a neutral 
stimulus (e.g., a light), with an aversive stimuli (e.g., electric shock). Following 
exposure, the animal will then be presented with an intense sound, which will 
produce a startle response. This startle response is potentiated with the 
additional presentation of the formerly neutral, but now conditioned, stimulus. 
There are a variety of drugs that reduce fear-potentiated startle in rats such as 
alpha-2 adrenergic agonists (e.g., clonidine), opioid receptor agonists (e.g., 
morphine), benzodiazepine/GABAA agonists (e.g., diazepam; Davis, Falls, 
Campeau, & Kim, 1993), and selective 5-H T ia receptor agonists (e.g., busiprone; 
Kehne, Cassella, & Davis, 1988). This type of cue-dependent fear has been 
reported to be exclusively reliant on the amygdala (Rogan & LeDoux, 1996), as 
NMDA (A/-methyl-D-aspartate) antagonists, a type of glutamate receptor, injected 
into the amygdala extinguish fear-potentiated startle (Falls, Miserendino, & Davis, 
1992; Miserendino, Sananes, Melia, & Davis, 1990).
Contextual Fear. The rat will experience an aversive stimulus (e.g., 
electric shock), but will not be exposed to a novel or cued stimulus. Later the rat 
will be placed back in the same context to assess if re-exposure to the same 
environment without the aversive stimulus will elicit fear (Luyten,
Vansteenwegen, van Kuyck, Gabriels, & Nuttin, 2011). SSRIs, 5-HT iA receptor 
agonists (Inoue, Kitaichi, & Koyama, 2011) as well benzodiazepines (Harris &
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Westbrook, 2001) that act to enhance the inhibitory effects of GABA (Haefely, 
1990), attenuate the symptoms associated with contextual fear. Lesioning of the 
amygdala, hippocampus, or periaqueductal gray results in varying anxiety levels 
determined by the animals’ “freezing” behavior. Inactivation of the amygdala and 
ventral, but not dorsal, periaqueductal gray reveal a reduction in freezing (or 
lower anxiety levels), whereas inactivation of the hippocampus produces a robust 
level of freezing only initially that is no longer apparent 24 hours later. This 
indicates there are both short- and long-term conditioned fear states (Kim, Rison, 
& Fanselow, 1993). Moreover, depleting the stress horomone (corticosterone) 
via an adrenalectomy in rats does not eliminate a contextual fear conditioning 
response immediately, but an alleviation of fear is noted 24 hours later (Pugh, 
Tremblay, Fleshner, & Rudy, 1997).
Voael Thirst-Lick Conflict Test. For this apparatus, water-deprived 
animals are given a reward of water while simultaneously receiving an electric 
shock to the tongue on every 21st lick. Animals that receive anxiolytics will 
continue consuming the water. However, control animals (who receive no drugs) 
will avoid the aversive stimulus (Bourin, Petit-Demouliere, Dhonnchadha, & 
Hascoet, 2007). Benzodiazepines have been reliable anxiolytics for either male 
or females, whereas in some pharmaceuticals such as SSRIs, e.g., fluoxetine, 
are effective in producing anxiolytic-like effects, only in male rats. It has also 
been suggested that the serotonergic activity in the dorsal hippocampus 
mediates this conflict behavior (Matsuo, Kataoka, Mataki, Kato, & Oi, 1996).
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Geller-Seifter Test. For the rat, a positive reinforcer (such as food) is 
obtained by performing an instrumental response (i.e., lever pressing). After the 
rat reaches a point where it is making consistent operant responses for the 
positive reinforcer, approximately seven trials later a negative reinforcer (i.e., 
electric shock) is added. The presentation of the positive reinforcer is 
simultaneously paired with electric shock to the rat, and, thus, creating a conflict 
between the positive and negative reinforcement (Geller, Kulak, & Seifter, 1962). 
5 -HT2C receptor antagonists (Kennett, Pittaway, & Blackburn, 1994) and 
benzodiazepines (Geller, Kulak, & Seifter, 1962) have shown anxiolytic 
properties, and encouraged rats to tolerate more shocks to obtain more food. 
Furthermore, a serotonergic antagonist injected into the basolateral amygdala 
results in anxiogenic effects for this particular conflict paradigm (Hodges, Green, 
& Glenn, 1987).
Defensive Burying Test. The rat will be placed in a cage filled with 
sawdust bedding where the rat will receive an electric shock from a stationary 
electrified prod. Typically, after receiving a shock, the rat will exhibit a passive 
behavioral response (i.e., inactivity) followed by a vigorous burying behavior to 
move the sawdust bedding onto and subsequently covering the electrified prod. 
This defensive burying is only seen when a shock is administered, so it does not 
occur in the absence of shock (Pinel & Treit, 1978; Treit, Pinel, & Fibiger, 1981). 
Benzodiazepines have been effective in reducing the defensive burying behavior 
(Treit, 1990; Treit et al., 1981). Furthermore, lesions to either the dorsal 
premammillary nucleus, anterior hypothalamus, or the dorsal medial portion of
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the ventromedial hypothalamus suppress unconditioned defensive behaviors 
(Canteras, 2002; Canteras & Swanson, 1992; Risold, Canteras, & Swanson, 
1994).
Unconditioned Animal Models of Anxiety
Elevated-Plus Maze. The elevated-plus maze is an effective animal 
model of anxiety. The design of this maze is an elevated platform with four arms. 
Two of the arms have surrounding walls, while the other two arms are open and 
without walls. The arms are interconnected by a central platform. Time spent 
navigating the maze, and the number of entrances in the open arms, are 
commonly used as measures of anxiety because of rats’ innate fear of novel, 
open spaces; while time spent in the closed arms is assessed as a measure of 
general motor activity (Ramos, 2008). SSRIs tend to induce, rather than 
ameliorate, behavior indicative of anxiety (Takeuchi, Owa, Nishino, & Kamei, 
2010). Furthermore, the performance of rats in the elevated-plus maze is 
unaltered by norepinephrine-based drugs (i.e., desipramine; Drapier, Bentue- 
Ferrer, Laviolle, Millet, Allain, Bourin, et al., 2007), however, serotonin- 
norepinephrine reuptake inhibitors (SNRIs) have produced results comparable to 
anxiolytic compounds, such as benzodiazepines (Takeuchi, Owa, Nishino,
Kamei, 2010).
Liaht-Dark Box. The light-dark box consists of two areas. The larger area 
has a white and brightly lit background, while the smaller area has a dark and 
black background. Exploration in the larger, illuminated white background is 
used as the measurement of anxiety (due to a rat’s innate fear of exposure to
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bright light; anti-phototropic). The assessment of anxiety is based on the time 
spent in the area, motor activity, and number of entries (Crawley & Goodwin, 
1981; Ramos, 2008). On a similar note to the elevated-plus maze, SSRIs are 
generally inactive in reducing anxiety and actually facilitate anxiogenic-like 
responses (Bodnoff, Suranyi-Cadotte, Quirion, & Meaney, 1989). 
Benzodiazepines, which are typically effective in reducing anxiety, do not have 
an impact in the light-dark box for rats, but do show anxiolytic properties for mice 
(Ramos, Pereira, Martins, Wehrmeister, &lzidio, 2008). The alpha-2 adrenergic 
antagonist (yohimbine) exerts anxiogenic effects in the light-dark box 
(Fernandez, Misilmeri, Felger, & Devine, 2004). In general, the light-dark box is 
likely not a reliable marker for screening anxiolytic compounds in rats (Ramos et 
al., 2008).
Holeboard Test. Rats are placed in a wooden box with four smaller holes 
located in the floor. Infrared photocells are placed on the sides of the box to 
detect locomotor activity and rearing. Photocells are also distributed below the 
surface of the holes to measure the frequency and duration of head-dips by the 
rat. Changes in head-dipping by rodents are believed to be a marker of anxiety, 
as increased head-dipping is considered an exploratory behavior that the rats 
would perform during less anxious states (File & Pellow, 1985; Takeda, Tsuji, & 
Matsumiya, 1998). Benzodiazepines have produced a significant increase in 
such exploratory behavior (File & Pellow, 1985). SSRIs and SNRIs have been 
advantageous in exhibiting anxiolytic properties in the hole board test (Ishizuka, 
Abe, Tanoue, Kannan, & Ishida, 2010).
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Novelty-Suppressed Feeding Test. In this animal mpdel, rats are foed 
deprived (not water-deprived) for 48hrs, and then placed in a novel environment 
with food where the latency to begin eating is recorded (Bodnoff, Suranyi- 
Cadotte, Aitken, Quirion, & Meaney, 1988; Bodnoff et al., 1989).
Benzodiazepines are effective anxiolytics (i.e., reduce latency to eat the food), 
whereas either a NSRI or SNRI is not nearly as effective (Bodnoff et al., 1988).
Adult Social Interaction Test. Two adult male rats are placed in the same 
environment and the interaction between the rats (e.g., sniffing, following, or 
grooming the other rat) is scored. Importantly, only one score for the pair of rats 
is used, as the behavior of one rat influences the behavior of the other.
However, if only one rat is treated (e.g., drug administration), then only that rat is 
scored. Animals that engage in more social interaction are less anxious, while 
decreased social interaction would illustrate the opposite effect. The highest rate 
of social interaction occurs between animals in a familiar environment with 
minimal lighting (File & Seth, 2003). Benzodiazepines have been effective in 
attenuating anxiety in this model (File & Pellow, 1984), whereas benzodiazepine 
receptor antagonists exhibit anxiogenic effects (File, Lister, & Nutt, 1982). 
Antidepressant drugs (e.g., SSRIs or tricyclic antidepressants) have been 
reported to have anxiogenic rather than anxiolytic responses (Bagdy, Graf, 
Anheuer, Modos, & Kantor, 2001; To, Anheuer, & Bagdy, 1999; To & Bagdy,
1999).
Juvenile Social Exploration Test. This test is similar to the adult social 
interaction test, but a key difference being the utilization of juvenile rats (28-32
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days old). In this model, 24hr before the administration of a stressor (e.g., 
electric shock), the rat is taken from the vivarium and placed in a plastic tub cage 
with bedding that is free of food and water. The rat is given 60 min to become 
acclimated to the novel environment, then a juvenile rat is placed in the cage with 
the adult rat where the researcher will record exploratory behaviors exhibited by 
the adult rat (e.g., sniffing, pinning, or grooming the juvenile). Additionally, 
behavior is only recorded for the one adult rat in the tub cage. After a few 
minutes the juvenile is removed, and the adult rat is returned to its home cage. 
This initial social exploration (SE) test is used as a baseline procedure to screen 
for rats with any abnormal responses prior to the stressor, as non-stressed rats 
will spend a significant portion of time exploring a juvenile. Following the 
preliminary screening step, the adult male will be tested again for SE at a later 
time point post-stressor (Christianson et al., 2008a). This procedure is slightly 
modified from other versions of SE (Bluthe, Dantzer, & Kelley, 1992; Poliak, 
Orion, Goshen, Ovadia, & Yirmiya, 2000;Pollak, Ovadia, Goshen, Gurevich, 
Monsa, Avitsur, et al., 2000; Poliak, Ovadia, Orion, & Yirmiya, 2003). It has been 
illustrated as a successful animal model of anxiety, as the administration of an 
anxiogenic (e.g., p-carbolines) or anxiolytic (e.g., benzodiazepines) compound 
resulted in either reduced or increased SE, respectively (Christianson et al., 
2008a).
This animal model of anxiety has three distinct advantages over adult 
social interaction: 1 The juvenile test takes place in a familiar tub cage, so the 
anxiety experienced by the adult rats is not due to novelty.2 Aggressive behavior
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is a far less common interaction with a juvenile compared to another adult rat 
(Blanchard, Wall, & Blanchard, 2003) leading to a clearer representation of 
anxiety.3 Typically in adult social interaction, the total amount of interaction time 
is involved with paired scoring for both adult rats, and, thus, requiring twice the 
number of rats and treatments to achieve the same statistical results.
Open Field Test. The open field test (Hall, 1934; Hall & Ballechey, 1932) 
is a widely adopted animal model of anxiety for rodents that typically utilizes an 
open-top square box (Belzung & Griebel, 2001; Prut & Belzung, 2003). When 
rats are experiencing anxiety, they do not explore new environments and hug the 
walls of the open field (a behavior known as thigmotaxis). The anxiety-related 
behavior is measured by the degree to which the rat avoids the center of the 
open field test (Christianson & Drugan, 2005; Walsh & Cummins, 1976). 
Behavioral responses in the open field can reveal signs of increased or 
attenuated anxiety levels when anxiolytic drugs (such as benzodiazepines and 
GABAa agonists; Prut & Belzung, 2003) and 5-H T ia  agonists, respectively, 
(Siemiatkowski, Sienkiewicz-Jarosz, Czlonkowska, Bidzinski, & Plaznik, 2000) 
are administered. However, behavioral measures are non-responsive to SSRIs 
(Durand, Berton, Aguerre, Edno, Combourieu, Mormede et al., 1999). Due to 
these tendencies, the open field test does appear to be a representative model of 
normal anxiety (i.e., similar to a daily stressor), but may not be representative of 
pathological anxiety associated with various anxiety disorders (Prut & Belzung, 
2003).
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All of these tests rely on the unconditioned avoidance of a threatening 
situation. Moreover, they all measure the conflict a rat has in the desire to 
explore new places, but also its natural fear of brightly lit or novel areas (i.e. 
neophobia). While all of the animal models would potentially be an effective 
measure of anxiety, the open field test is ideal in order to compare its effects to 
past work in our laboratory (Christianson et al., 2008b).
Specific Aims
Inescapable shock has been correlated with c-Fos expression in the DRN 
(Amat et al., 2005) and LC. However, exposure to either inescapable shock or 
escapable shock in the LC, while both producing elevated levels of c-Fos 
expression, shows no difference in the amount of c-Fos expressed. This 
suggests that the LC is not sensitive to stressor controllability for electric shock 
(McDevitt et al., 2009). Exposure to ISS is suggested to activate neural 
substrates differently compared to electric shock (Drugan et al., 2010; Warner & 
Drugan, 2012). Generally, the ISS model tends to be unresponsive to various 5- 
HT manipulations and 5-HT-based antidepressants (Christanson et al., 2008b; 
Drugan et al., 2010), while norepinephrine-based antidepressants have had 
favorable results in alleviating ISS-induced deficits (Drugan et al., 2010; Warner 
& Drugan, 2012).
The following experiments will explore the implications of serotonergic and 
noradrenergic neurons in the DRN and LC, respectively, following ISS exposure 
and its possible association with anxiety. The effects of ISS will also be 
evaluated, behaviorally, with two animal models of anxiety (i.e., open field test
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and SE). Experiment 1 used double-labeled TPH and TH/c-Fos 
immunohistochemistry (IHC) in the brain to detect the neural activity in the DRN 
and LC, as well as the open field test to monitor anxiety behavior. However, 
increased anxiety-like behavior was not depicted with the behavioral analysis 
from the open field data. As a result, experiments 2 and 3 will address the same 
concerns as the preceding experiment, but will investigate a different behavioral 
endpoint for anxiety (i.e., SE) with experiment 2 being a preliminary experiment 






48 male Sprague-Dawley rats (SAS Derived, Charles River Labs, NY, 
USA) each weighing between 180-200 grams were used in the experiment. For 
the first week, animals were allowed the allotted time to acclimate to the 
vivarium. During that time the rodents were housed four to a cage, while food 
and water was provided ab libitum. The vivarium was maintained on a 12-hour 
light/dark cycle (6:00am to 6:00pm) with the light cycle beginning at 6:00am. All 
procedures were conducted during the first 6 hours of the light cycle. After the 
first day of procedures, animals were individually housed in tub cages and given 
food and water ab libitum. In addition, all procedures were reviewed and 
approved by the University of New Hampshire Institutional Animal Care and Use 
Committee (IACUC; APPENDIX A).
Apparatus
Intermittent Swim Stress. ISS was conducted in two Plexiglas cylinders 
(21cm diameter X 42cm height) with a !4-inch galvanized wire mesh at the 
bottom of each cylinder that was suspended over a tank (28.6cm height, 80.6cm 
length, and 45.7cm width). The tank was filled with water that reached a depth of 
20cm, with the water maintaining a temperature of 15±1°C (ice was consistently
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added to ensure that the temperature remained constant). During the ISS 
treatment, a rat was placed in each cylinder and both cylinders were lowered 
(simultaneously) into the cold water where the rats were forced to swim. The 
cylinders remained in the water for 5 seconds, and then retracted to their original 
placement (12.7cm above the water). Over the duration of ISS, space heaters 
(two above and two in front of each cylinder) blew warm air (~36°C) to keep the 
rats warm in between swim trials. The swim stress apparatus was monitored by 
the means of a computer with med-PC hardware and software that controlled the 
movement of the cylinders on a variable interval-60sec schedule (Christianson & 
Drugan, 2005).
Open field Test. Open field tests were conducted in an open-top square 
plywood box (25cm height, 120cm length, and 120cm width) painted with flat 
black enamel. A cool white fluorescent lamp emitted 200-300 lux throughout the 
box. Open field test sessions were recorded with a video camera located directly 
over the center of the arena.
Procedure
On the first day of experimentation, rats were randomly assigned to one of 
six conditions: home cage control (HCC)/open field, confined control (CC)/open 
field, ISS/open field, HCC/HCC, CC/HCC, or ISS/HCC with 8 rats/group. ISS 
rats were exposed to 100-5sec forced swims in the cold water (15°C) on a 
variable interval (Vl)-60sec schedule (range = 10 -  100sec) in a procedure that 
we have shown to produce behavioral depression (Christianson & Drugan,
2005). CC rats were placed in the same apparatus and put through the same
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intermittent procedure, but in the absence of water. After being exposed to the 
swim stress, ISS rats were warmed under incandescent lamps (75W just above 
the cage top) for 30 min while CC rats were placed under lamps positioned 90cm 
above the cage to control for light exposure. Following the warming period, all 
rats were returned to the vivarium. The HCC rats were never exposed to the ISS 
apparatus to ensure that the CC animals were a reliable control group.
On day two, depending on the condition, rats would either experience the 
open field test or remain in the vivarium as a HCC. Rats were placed in the open 
field test for 10 min with the each rat initially being placed in the center of the 
open field arena. The frequency of the following behaviors was recorded: 
grooming (using paws or tongue to clean itself), rearing (standing on hind legs), 
and corner facing (time spent facing a comer of the box). Time spent in the outer 
and inner sections of the arena was recorded. The outer section of the box was 
defined as all of the squares on perimeter of the walls, which included the four 
comers (i.e., 20 of 36 squares). The remaining region of the arena (16 squares) 
was defined as the inner section or center. Locomotor activity was recorded as 
number of line crossings (all four paws crossing a line; Hale et al., 2008a). The 
experimenters making the behavioral assessments were blind to group 
membership.
Tissue Collection and Preparation
90 min after the behavioral testing (e.g., open field test) rats were 
perfused (Sartor & Aston-Jones, 2012). Prior to perfusions, all rats were injected 
with a mixture of 80 mg/kg of ketamine and 8 mg/kg xlyazine of the animal’s body
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weight for the anesthetic. The researcher would pinch a paw of the animal firmly 
to ensure there was no longer a pain reflex for the rat. If there was still pain 
reflex, supplemental doses of 0.10 ml of ketamine were administered as needed 
to ensure that the rat was heavily sedated. When rats were sedated, they were 
transcardially perfused with physiological saline (0.9% sodium chloride; pH 7.4) 
followed by 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH 
7.4). Following the perfusion, brains were extracted from the skulls of the rats 
and stored in small glass containers with the fixative solution (4% 
paraformaldehyde in 0.1 M PB). 12-16 hours later, the brains were transferred 
into PB (2 X 12 h). After being in the PB, the brains were then stored in 30% 
surcrose in PB until they had sunk to the bottom of the glass containers. With 
the use of a rat brain matrix (RBM-4000C, ASI Instruments, Warren, Ml, USA), 
each brain was sectioned into the forebrain and hindbrain at the caudal portion of 
the mammillary bodies, and stored at -80°C until further processing. The 
hindbrain, which included the midbrain raphe complex and locus coeruleus 
complex, was sliced into 30pm sections using a cryostat (Leica CM1900, Leica 
Microsystems Ltd., Buckinghamshire, UK). The sections were placed in 6 
different wells containing a cryoprotectant solution (30% ethylene glycol, 20% 
glycerol in 0.05 M PB; pH 7.4) in a 24 well-culture plate. Each well contained a 
representative set of sections at 180pm intervals throughout the midbrain raphe 
complex. After the slicing was completed in the cryostat, the sections were 
stored at -20°C.
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Immunohistochemistrv: Tryptophan Hvdroxvlase (TPH) and c-Fos
A set of hindbrain sections, including the midbrain complex, was removed 
from one of the 6 wells in a 24-well tissue culture plate. The tissue sections from 
each animal were placed in a 12-well tissue culture plate where the tissue was 
free-floating in 1 ml solutions at room temperature, and gently shaken on an 
orbital shaker throughout the immunohistochemistry. All tissue underwent a 
double-immunostaining process using primary antibodies for the protein product 
of the immediate early gene, c-fos (rabbit anti-c-Fos polyclonal antibody, Cat. No. 
PC38, Lot No.D00109969,1:3000; Calbiochem, EMD Chemicals, Gibbstown, NJ, 
USA) and TPH (sheep anti-TPH antibody, Cat. No. T8575, Lot No. 010M1152, 
1:12,000; Sigma-Aldrich, St. Louis, MO, USA). Immunohistochemistry was run 
simultaneously for all rats in experiment 1 in order to limit variability in the 
staining process. All washes or rinses during the staining process were 15min 
each, unless otherwise noted. On the first day of the immunostaining, tissue was 
rinsed from the cryoprotectant twice in 0.05 M phosphate buffered saline (PBS), 
then placed in 1% hydrogen peroxide in 0.05 M PBS, and followed by two rinses 
in 0.05 M PBS. Then the tissue was washed in 0.05 M PBS containing Triton X- 
100 (PBST; 0.03%), and incubated overnight with rabbit anti-c-Fos antibody in 
0.01% PBST with 0.01% sodium azide. 12-16 hours later, on day 2, the antibody 
was rinsed off twice in 0.05 M PBS, followed by a 90 min incubation in a 
biotinylated donkey anti-rabbit secondary antibody (Cat. No. 711065152, Lot 
No. 104183,1:500; Jackson ImmunoResearch, West Grove, PA, USA) in 0.05 M 
PBS. Then the tissue was rinsed twice in 0.05 M PBS, followed by a 90 min
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incubation with an avidin-biotin-peroxidase complex (Elite ABC reagent, Cat. No. 
PK-6106,1:200; Vector Laboratories, Burlingame, CA, USA). Tissue was then 
rinsed twice with 0.05 M PBS, followed by incubation in a peroxidase chromogen 
substrate (Vector SG; Cat. No. SK-4700; Vector Laboratories; diluted as 
recommend by vendor) in 0.05 M PBS for 32 min. Immediately after the 
chromogen reaction was complete, the tissue was rinsed in 0.05 M PBS two 
separate times to terminate the reaction. Tissue was washed in 1% hydrogen 
peroxide in 0.05 M PBS, followed by two rinses in 0.05 M PBS, and then 
incubated with sheep anti-TPH antibody in 0.1% PBST with 0.01% sodium azide 
overnight. 12-16 hours later, on day 3, the antibody was rinsed off with two 
washes in 0.05 M PBS, followed by a 90 min incubation in a biotinylated rabbit 
anti-sheep secondary antibody (Cat. No. PK-6106,1:200; Vector Laboratories, 
Burlingame, CA, USA) in 0.05 M PBS. Then the tissue was washed twice in 0.05 
M PBS followed by a 90 min incubation with an avidin-biotin-peroxidase complex 
(Elite ABC reagent, Cat. No. PK-6106,1:200; Vector Laboratories, Burlingame, 
CA, USA). The tissue was rinsed twice with 0.05 M PBS, then placed in a 
peroxidase chromogen substrate solution consisting of 0.01% 3,3'- 
diaminobenzidine tetrahydrochloride (DAB) in 0.05 M PBS, with the reaction 
activated prior to use with 0.005% hydrogen peroxide, for 80 min. The result of 
the reaction was faint, so the tissue was rinsed twice in 0.05 M PBS, and 
incubated once more with sheep anti-TPH antibody in 0.1% PBST with 0.01% 
sodium azide overnight, increasing the concentration of TPH from 1:12,000 to 
1:8,000. 12-16 hours later, on day 4, all steps were the same as day 3
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(excluding primary antibody). Following a successful reaction in DAB, the tissue 
was washed twice in 0.05 M PBS to stop the reaction, and then placed 0.1 M PB 
with 0.01% sodium azide at 4°C. Immunostaining of c-Fos was a blue/black 
color localized to the nucleus, while immunostaining of TPH was an 
orange/brown color localized to the cytoplasm. Following immunostaining, the 
tissue was rinsed briefly in 0.15% gelatin in distilled water, then mounted on 
microscope slides (VistaVision, Cat No. 16004-390, VWR, West Chester, PA, 
USA). The mounted tissue was dehydrated through the use of a series of graded 
alcohols (70%, 95%, and 100% ethanol) and cleared with xylene. Cover slips 
were then secured on the slides using Entellan mounting medium (Electron 
Microscopy Science, Hatfield, PA, USA).
Immunohistochemistry; Tvrosine Hvdroxvlase (TH) and c-Fos
This process was virtually identical to the TPH protocol that was 
previously described with exceptions in two key areas. On day 2, the primary 
antibody that was used was TH (rabbit anti-TH, Cat. No. AB152, Lot No. 
21030329,1:8000; Chemicon, Billerica, MA, USA) and was incubated for 12-16 
hours. On day 3, the secondary antibody that was used was a biotinylated 
donkey anti-rabbit secondary antibody (Cat. No. 711065152, Lot.No. 104183, 





A One-way analysis of variance (ANOVA) revealed no significant differences 
between ISS and control rats for any of the behavioral measures (i.e, rearing, 
grooming, comer facing, time spent in the outer/inner sections and locomotor 
activity) in the open field test (p’s > 0.05; Figures 1-6). The open field data was 
analyzed in the same format as Hale et al. (2008a) in terms of the grouping the 
data in five minute segments (i.e., 0-5 min and 5-10 min).
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Figure 1. Mean (+/- SEM) frequencies of behavior in the open field (0-5 min). 
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Figure 2. Mean (+/- SEM) time in sec spent in the outer or inner section of the 
open field (0-5 min).
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Figure 3. Mean (+/- SEM) number of line crossings in the outer or inner section of 
the open field (0-5 min).
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Figure 4. Mean (+/- SEM) frequencies of behavior in the open field (5-10 min).
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Figure 5. Mean (+/- SEM) time in sec spent in the outer or inner section of the 
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Figure 6. Mean (+/- SEM) number of line crossings in the outer or inner section of 
the open field (5-10 min).
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Immunohistochemsitrv for the DRN
Cell counting occurred in the dorsal part of the dorsal raphe nucleus (DRD) at - 
8.18mm Bregma (Paxinos & Watson 1997). The immunohistochemistry data for 
three rats was omitted due to the quality of the tissue. A Pearson’s r revealed 
that the inter-rater reliability correlations were high for all three cell counts: 
r(43)=0.93 for c-Fos, r(43)=0.90 for TPH-stained neurons, and r(43)=0.95 for 
double-labeled neurons (p<0.001 for all counts). A repeated measures ANOVA 
was used with mean cell counts for c-Fos, TPH-stained (serotonergic) neurons, 
and double-labeled (presentation of c-Fos and TPH in same cell) as the within- 
subject factors and treatment as the between-subject factor. There was a 
significant difference for cell counts [F(2,78) = 307.68, p < 0.001], but there was 
not a significant effect for cell counts X treatment interaction [F(10,78) = 0.570, p 
= 0.833]. There was also no significant difference between the treatment groups 
[F(5,39) = 0.527, p = 0.755]. This indicated that the number of counts between c- 
Fos, TPH-stained neurons, and double-labeled neurons did differ. However, the 








Figure 7. Mean (+/- SEM) counts for cells containing c-Fos, TPH, and both c-Fos 
and TPH (double-labeled) in the DRD (dorsal part of the dorsal raphe nucleus) at 
-8.18mm Bregma.
Figure 8. Photomicrograph representing a sample of c-Fos expression in 
serotonergic and non-serotonergic neurons in the mid-rostrocaudal dorsal raphe 
nucleus (-8.18mm Bregma). Black boxes indicate regions with higher levels of 
magnification in inserts in the lower left part of the panel. Black arrows illustrate 
examples of c-Fos (represented by a blue/black coloring of the nucleus), white 
arrowheads indicate TPH-stained cells (represented by brown/orange coloring of 
the cell body), and black arrowheads indicate the presentation of both c-Fos and 
TPH in the cell (double-labeled neurons).
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Immunohistochemsitrv for the LC
Cell counting occurred between -9 .8  and -10.04 mm Bregma (Paxinos & 
Watson 1997). The immunohistochemistry data for six rats was omitted due to 
missing sections. A Pearson’s r revealed that the inter-rater reliability 
correlations were high for all three cell counts: r(40)=0.97 for c-Fos, r(40)=0.92 
for TH-stained neurons, and r(40)=0.97 for double-labeled neurons (p<0.001 for 
all counts). A repeated measures ANOVA was used with mean cell counts for c- 
Fos, TH-stained (noradrenergic) neurons, and double-labeled (presentation of c- 
Fos and TH in same cell) as the within-subject factors and treatment as the 
between-subject factor. There was a significant difference for cell counts 
[F(2,72) = 940.94, p < 0.001], but there was not a significant effect for cell counts 
X treatment interaction [F(10,72) = 0.879, p = 0.557]. There was also no 
significant difference between the treatment groups [F(5,36) = 0.982, p = 0.442]. 
This indicated that the number of counts between c-Fos, TH-stained neurons, 
and double-labeled neurons did differ. However, the cell counts did not differ 
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Figure 9. Mean (+/- SEM) counts for cells containing c-Fos, TH, and both c-Fos 
and TH (double-labeled) in the LC between -9 .8  and -10.04 mm Bregma.
Figure 10. Photomicrograph representing a sample of c-Fos expression in 
noradrenergic and non-noradrenergic neurons. Black boxes indicate regions 
with higher levels of magnification in inserts in the lower left part of the panel. 




The non-significant results for the open field test could mean that 
exposure to the ISS model may better represent pathological anxiety. Indeed, if 
this is the case, Prut and Belzung (2003) have suggested that the open field test 
may not be a valid model to characterize pathological anxiety. In terms of the 
immunohistochemistry, the cell counting that occurred in the DRD at -8.18mm 
Bregma was chosen because it is densely populated with serotonergic neurons 
and has a strong association with anxiety. Expanding on the DRD’s association 
with anxiety: it is innervated by structures in the forebrain (e.g., BNST), which 
control anxiety levels; plays a role in mediating emotional behavior; and is a key 
area that responds specifically to stress- or anxiety-provoking stimuli (Lowry et 
al., 2008). The selected sections between -9 .8  and -10.04 mm Bregma were 
chosen because the largest portion of noradrenergic neurons are found in this 
rostrocaudal area (Dawe, Huff, Vandergriff, Sharp, O’Neill, & Rasmussen, 2001) 
and this area is innervated by amygdala, which is associated with fear and 
anxiety (Bishop, 2007).
The results obtained from the current experiment for both the c-Fos/TPH 
and c-Fos/TH protocols revealed no differences between the treatment groups. 
With the similar results between the stress and control conditions, this could 
mean that serotonergic neurons may not play as large of a role with regard to 
ISS —  a consistent finding with our model (Christianson et al., 2008b; Drugan et 
al., 2010). However, NSRIs have been effective in alleviating ISS-induced 
deficits (Drugan et al., 2010), even though there was no difference at the cellular
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level for noradrenergic neurons in the current experiment. The lack of cellular 
results could be due to when the assessment of c-Fos occurred (approximately 
24h after ISS exposure), since c-Fos is a short-lived protein with a half-life of 
approximately two hours. This alludes to the importance of the time course 
associated with c-Fos, and could provide an opening for other longer lasting Fos 





Contrary to experiment 1, SE was used as the dependent measure rather 
than the open field test (described below). The rationalization to use SE as a 
different behavioral endpoint to measure anxiety was derived from prior work by 
Christianson, Drugan, Flyer, Watkins, and Maier (2013) who found a significant 
difference in SE for rats exposed to a cold water continuous swim (19°C) with a 5 
min swim duration. Differences in SE were noted at 1 hr and 24hr post-stress. 
However, for our model, looking at the effects 1 hr post-ISS may yield 
confounding results, as rats demonstrate hypothermic tendencies for at least 2hr 
post-ISS (Levay, Govic, Hazi, Flannery, Christianson, Drugan et al., 2006). With 
that known, experiment 2 was a pilot study to determine the optimal time point 
post-ISS (15°C; 100-5 sec swims) to evaluate SE.
Subjects
All rats were exposed to ISS. 16 male Sprague-Dawley rats (SAS 
Derived, Charles River Labs, NY, USA) were divided into two groups: No Context 
Re-Exposure and Context Re-Exposure with 8 rats/group. All procedures were 




Juvenile Social Explpration. This censisted of a single, plastic tub cage 
(20.3cm height, 47.6cm length, and 25.4cm width) that contained wood shavings 
as bedding and a metal wire lid, but free of food and water. Test sessions were 
recorded with RT counter/timer version 2.1 (an open-source laboratory timer 
written by John Christianson, 2007) used by Christianson et al. (2008a). 
Procedure
On days 1 (48hr pre-ISS; SE 1) and 2 (24hr pre-ISS; SE 2) of 
experimentation, rats underwent baseline tests for SE. Two baseline tests were 
administered to ensure that the amount of time the rats spent exploring the 
juveniles was consistent across multiple time points. For the test itself, adult (4 
rats/cage) and juvenile (6 rats/cage) rats were group housed and were taken 
from the vivarium and placed in a separate room from either the vivarium or ISS 
room. All rats were given 60 min to become acclimated to the novel 
environment, then a juvenile rat (28-32 days old) was placed in a separate cage 
with an adult rat for three minutes where exploratory behaviors (e.g., sniffing, 
pinning, or grooming the juvenile) of the adult rat was recorded. After three 
minutes the juvenile was removed, and the adult rat was returned to its home 
cage (Christianson et al., 2008a).
Day 3 was the same as the first day of experimentation for experiment one 
with the exception of there being no CC condition, only ISS. Following ISS 
exposure, adult rats were individually housed (this was the housing condition for 
the remainder of the experiment). Juvenile rats always remained group housed
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throughout the experiment. The adult rats were divided into two groups: No 
Context Re-Exposure and Context Re-Exposure. The first group would 
experience ISS, but was not re-exposed to the ISS apparatus at later time points. 
For the Re-Exposure group, those rats were re-exposed to the ISS apparatus for 
10 minutes prior to each SE time point post-ISS. Regardless of the group, SE 
testing occurred at 3h (SE 3), 5h (SE 4), 8h (SE 5), and 24h (Day 4; SE 6) post- 
ISS. All of these SE tests were compared to the baseline measures— SE 1 and 
SE 2. The exact procedure described for SE on days 1 and 2 remained the 
same with the exception that the Re-Exposure group only experienced a 50 min 
acclimation to the SE room prior to testing. Important to note, is that all of the 
time points selected occurred during the light cycle.
Results
A Pearson’s r revealed that the inter-rater reliability was high for all SE 
tests: r(14)=0.99 for SE 1-SE 6 (p<0.001). A one way ANOVA was conducted to 
determine the statistical significance between groups, and revealed a significant 
main effect [F(11,95) = 2.713, p = 0.005]. Post hoc Fisher’s Least Significant 
Difference (LSD) tests indicated that the No Re-Exposure/SE 1 and SE 2, 
respectively, differed from SE 4 (p = 0.005; p = 0.006), SE 5 (p = 0.015; p = 
0.017), and SE 6 (p = 0.002; p = 0.003). The same post hoc tests also revealed 
that the Re-Exposure/SE 1 and SE 2, respectively, only differed from SE 5 (p = 
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Figure 11. Mean (+/- SEM) time in sec of social exploration. All rats were 
exposed to ISS, but were divided into No Re-Exposure or Re-Exposure groups. 
There were 6 social exploration time points (48h pre-ISS = SE 1; 24h pre-ISS = 
SE 2; 3h post-ISS = SE 3; 5h post-ISS = SE 4; 8h post-ISS = SE 5; 24h post-ISS 
= SE 6). ‘ Significant difference (p<0.05) from SE 1 and SE 2 for only the No 
Context Re-Exposure condition. “ Significant difference (p<0.05) from SE 1 and 
SE 2 for both experimental conditions.
Discussion
Even though there was no discernible difference noted for the open field test in 
experiment 1, the results for the current experiment provide the first behavioral 
change of anxiety behavior in response to ISS exposure. Others have noted a 
reduction in SE 24h post-stress without re-exposure to the stressful environment 
(Christianson, Jennings, Ragole, Flyer, Benison, Barth, etal., 2011), and most 
studies have looked at the effects of juvenile SE 12 hours or later following stress 
exposure (Christianson et al., 2008a, 2011). However, because SE has never
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been explored with regard to ISS, it was vital to assess multiple time points to 
ensure an effect was possible. The inconsistent results of the context re­
exposure group was likely due to the fact that the 60 min acclimation period in 
the SE testing room was disrupted when the animals were placed back in the ISS 
chamber. So, in the subsequent experiment, no context re-exposure will occur. 
Since there was no statistical difference between SE 1 and SE 2, only one SE 





With the results being much more consistent and reliable for the no 
context re-exposure group, I did not plan to pursue the context re-exposure 
condition for experiment 3. Moreover, the goal of the previous experiment was to 
select an optimal time point. A 24h SE time point seemed ideal for experiment 3 
for a few reasons:1 This time point was consistent with our past work in our 
laboratory that has looked at the effects of ISS 24h later on various behavioral 
endpoints (Christianson & Drugan, 2005; Drugan, Eren, Hazi, Silva, Christianson, 
& Kent, 2005; Drugan et al., 2010; Warner & Drugan, 2012)2 This was the same 
time point that was investigated in experiment 1 3 Due to our general interest in 
serotonin and norepinephrine with our ISS model, there have been previous 
reports looking at the mechanistic functions of dorsal raphe nucleus and locus 
coeruleus at a 24h time point. At 24h post-uncontrollable stress, there was an 
increase in the firing rate of serotonin in the dorsal raphe nucleus (Rozeske et al., 
2011) and a decrease in the firing rate of norepinephrine in the locus coeruleus 
(Pavcovich & Ramirez, 1991). 4 In the small chance that the multiple SE tests 
affected performance 24h post-ISS, a 24 time point was measured again to 
provide a pure assessment of the results. This was helpful to ensure that fatigue 
or hypothermia was not a potential confound for the reduced SE times. The
52
methodology was identical to experiment 2 with the exception of the groups and 
only two SE time points were used.
Subjects
16 male Sprague-Dawley rats (SAS Derived, Charles River Labs, NY, 
USA) were divided into two groups: ISS and home cage control (HCC) with 8 
rats/group. A CC group, as seen in experiment 1, was not included for this 
experiment. The reason being is that past results between the CC and HCC 
groups have been comparable (Christianson & Drugan, 2005), and most 
research involving an uncontrollable stressor only uses a HCC group 
(Christianson et al., 2008a, 2009, 2010). All procedures were reviewed and 
approved by the University of New Hampshire IACUC (APPENDIX C).
Procedure
Day 1, all adult and juvenile rats were group housed (4 rats/cage) and 
experienced SE 1 (24h pre-ISS). Day 2, only adult rats were individually housed 
and this was the housing condition for the remainder of the experiment. On this 
same day, for the ISS condition only, rats were exposed to the ISS apparatus. 
HCC rats remained in the vivarium during ISS sessions. Day 3, all rats 
experienced SE 2 (24 post-ISS).
Results
A Pearson’s r revealed that the inter-rater reliability was high for all SE 
tests: r(14)=0.99 for SE 1 and SE 2 (p<0.001). A one way ANOVA was 
conducted to determine the statistical significance between groups and revealed 
a significant main effect [F(3,29) = 4.757, p = 0.009]. Post hoc LSD tests
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indicated that ISS/SE 2 significantly differed from ISS/SE 1 (p = 0.001), HCC/SE 
1 (p = 0.011), and HCC/SE 2 (p = 0.018; Figure 12). One rat was removed from 














Figure 12. Mean (+/- SEM) time in sec of social exploration. There were 2 social 
exploration time points (24h pre-ISS = SE 1; 24h post-ISS = SE 2). * ISS group 
at SE 2 significantly differed (p<0.05) from all other conditions and SE time 
points.
Discussion
The present experiment replicates the reduction of SE following ISS 
exposure. Importantly, these results support the trans-situational value of the
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ISS model. ISS-induced deficits have been noted for tasks assessing behavioral 
depression (Drugan et al., 2010), learning and memory (Warner & Drugan, 2012) 
and now anxiety. As stated earlier, this SE reduction 24h post-stress has been 




We have learned much since the ISS model was first described by Brown, 
Hurley, Repucci, and Drugan (2001). Researchers illustrated the feasibility of 
using a triadic design (i.e. escapable stress, yoked-inescapable stress and a 
non-stressed control) with the ISS model, which was previously only associated 
with the tailshock paradigm (Maier et al., 1986). Controllability over the stressor 
(i.e., escapable swim stress) was not a factor at 23°C (Brown et al., 2001), but 
was a factor at 30°C (Drugan et al., 2005) for ISS in regards to behavioral 
depression (or immobility) in the FST. At 30°C, rats exposed to inescapable 
swim stress experienced greater immobility compared to rats that experienced 
escapable swim stress (Drugan et al., 2005). The stressor appeared to have a 
more severe impact at 23°C since both inescapable and escapable stress groups 
showed a significant reduction for immobility in comparison to controls (Brown et 
al., 2001), and this ISS-induced deficit has since been replicated for inescapable 
stress using 15°C (Christianson & Drugan, 2005; Drugan et al., 2010). The 
impairments associated with ISS extend beyond immobility, as there have been 
instrumental (Christianson & Drugan, 2005) and spatial (Warner & Drugan, 2012) 
learning deficiencies as well. Furthermore, stress-induced analgesia noted for 
inescapable tailshock (Drugan et al., 1985; Maier, Davies, Grau, Jackson, 
Morrison, Moye, et al., 1980) was also observed for inescapable swim stress 
(Brown et al., 2001).
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There have also been distinct differences between inescapable shock and 
swim paradigms. In response to alcohol, inescapable shock potentiated ataxic 
effects (Drugan, Coyle, Healy, & Chen, 1996) while inescapable swim either 
attenuated or had no influence on ataxia (Brown et al., 2001; Drugan, Wiedholz, 
Holt, Kent, & Christianson, 2007; Tayyabkhan, Mammola, & Drugan, 2002). In 
addition, there appear to be varying neurochemical systems regulating these 
different forms of inescapable stress. Learned helplessness resulting from 
inescapable shock is believed to derive from a serotonergic activation (Amat et 
al., 1998) and noradrenergic inactivation, (Amat et al., 2004), as inescapable 
shock produced large increases in 5-HT (Amat et al., 1998) and decreases in 
norepinephrine (Weiss & Simson, 1986). Fluoxetine, an SSRI, has been shown 
to alleviate the behavioral deficits imposed by inescapable shock (Valentine,
Dow, Banasr, Pittman, & Duman, 2008). However, fluoxetine has had no impact 
on the behavioral deficits associated with ISS (Christianson et al., 2008; Drugan 
et al., 2010), while NSRIs (e.g., desipramine and reboxetine) have mitigated such 
behavioral deficits (Drugan et al., 2010; Warner & Drugan, 2012). As a result, 
the nature of the stressor can have a profound influence on both the behavioral 
and neurological outcomes.
A key characteristic of uncontrollable stress is that it is believed to be 
trans-situational, meaning once the subject is removed from the original stressful 
encounter, the resulting experience is capable of altering the subject’s behaviors 
in different environments (Maier & Watkins, 2005). Results of the first 
experiment were inconsistent with this pattern as assessed via the open field
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test. This open field result also differed from shock studies, which have revealed 
shock-induced behavioral deficits in the open field at 24h (Weyers, Bower, & 
Vogel, 2008) and 48h (Li, Yang, Yue, Liu, Yu, Wang et al., in press) post-shock 
stress. The difference in the behavioral outcomes of the open field between 
inescapable shock and swim was intriguing. Perhaps, inescapable shock is a 
more taxing stressor in comparison to inescapable swim, but both, as previously 
described, have resulted in various deficits, and there is also a noted elevation in 
corticosterone for animals exposed to both inescapable shock (Maier, Ryan, 
Barksdale, & Kalin, 1986) and swim (Drugan et al., 2005). Because the open 
field results are one of the few instances where inescapable shock and swim 
vary, the ISS apparatus may provide a belter representation of pathological 
anxiety of which the open field may not validly measure (Prut & Belzung, 2003).
Later experiments provided justification of the trans-situational experience 
of ISS, and the first demonstration on anxiety behavior, as rats exposed to ISS 
had significant reductions in SE for both experiment 2 and 3. Although the trans- 
situational effects of ISS exposure have been suggested in the past using the 
FST (Brown et al., 2001; Christianson & Drugan, 2005; Drugan et al., 2005;
2010) and MWM (Warner & Drugan, 2012), the contextual similarity of water 
between all of the paradigms employed (i.e., FST, and MWM) could act as a cue 
for remembering the ISS paradigm. An ISS-induced deficit for the SE tests 
provides further validation for the trans-situational value of this particular 
uncontrollable stressor. The importance of this evidence is emphasized, as 
water did not serve as a contextual cue in this case, and this was also the first
58
behavioral measure of anxiety to reveal a significant impairment following ISS 
exposure. The SE reduction 24h post-stress is also comparable to the results 
seen for inescapable shock (Christianson et al., 2008a, 2011). Additionally, for 
both experiment 2 and 3, the ISS-induced deficit associated with SE occurred 
24h after the stressor, which is consistent with other behavioral endpoints in our 
laboratory (Drugan et al., 2010; Warner & Drugan, 2012).
While we have investigated a variety of behavioral endpoints following 
exposure to ISS, we have yet to examine the cellular mechanisms associated 
with the resulting ISS paradigm. Experiment 1 was intended to shed light on this 
new area. However, no significant difference between any of the groups was 
identified when comparing the stress-induced activation of serotonergic neurons. 
This result was consistent with expectations based on previous pharmacological 
manipulations in our laboratory (Christianson et al., 2008; Drugan et al., 2010), 
and indicated that norepinephrine may cause the impairments associated with 
the ISS model (Drugan et al., 2010; Warner & Drugan, 2012). Results of 
experiment 1 also demonstrated that there was no significant difference in 
noradrenergic activity for rats. Importantly, baseline assessment (i.e., not being 
exposed to the open field) of ISS exposure in this experiment revealed no 
difference in neurological activation (with regard to serotonergic and 
noradrenergic activity) between the controls. A contributing factor to the lack of 
differences between groups may be due to the short-lived expression of c-Fos.
In general, c-Fos is expressed in most cell types at all times in either low or 
undetectable levels and can become more readily transparent through exposure
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to various stimuli (Eferl & Wagner, 2003). Following acute stress, the maximum 
amount of c-Fos protein is expressed at 1-3 hours, and gradually disappears 
from detection at 4-6 hours. (Cullinan, Herman, Battaglia, Akil, & Watson, 1995; 
Kovacs, 1998; Kovacs & Sawchenko, 1996). However, past studies have noted 
significant elevations in c-Fos exposure for both serotonergic and non- 
serotonergic cells in the dorsal raphe nucleus merely from exposure to the open 
field arena (Hale et al., 2008a). So, it was surprising that exposure to the open 
field arena 90 min prior to sacrificing the animals for experiment 1 did not yield 
some type of variation from the home cage condition.
Given this information, differences may still exist at the cellular levels for 
serotonergic and noradrenergic neurons resulting from ISS exposure, but 
different methods need to be employed upon further exploration such as 
assessing IHC with SE, assessing IHC shortly after ISS, or using a different Fos 
protein. The following expands on these three points.1 Investigation of the 
cellular mechanisms associated with SE exposure noted in experiment 3. 
Exposure to the open field for experiment one may not have provided a strong 
enough stimulus to elicit a disparity between experimental conditions. In both 
experiment 2 and 3, there was a noted SE reduction for rats exposed to ISS. As 
a result, the SE task appears to provide varying levels of anxiety for rats exposed 
to ISS or a control condition. It will be important to consider the neurological 
implications previously described with this particular anxiety-related measure, as 
the evaluation of c-Fos following juvenile social exploration has not been 
discussed in the literature. In taking this into consideration, data analysis will be
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explored in the near future for the involvement of cellular mechanisms in 
experiment 3 .2 The assessment of c-Fos must occur shortly after the rats have 
experienced the ISS condition to assess a baseline measure of the paradigm. 
Two hours following ISS exposure may be an ideal time to evaluate c-Fos in the 
paradigm, as the rats are no longer in a hypothermic state (Levay et al., 2006) 
and the maximum amount of c-Fos expression occurs 1-3 hours following a 
stressor (Cullinan, Herman, Battaglia, Akil, & Watson, 1995; Kovacs, 1998; 
Kovacs & Sawchenko, 1996). Two hours post-inescapable stress has also been 
used for tailshock to assess the protein product of c-Fos (Christianson et al.,
2011).3 Implementing different neural markers (e.g., FosB and Fos-related 
antigens) to evaluate cellular mechanisms. FosB has a half-life of 9.5 hours 
following acute challenges, which would likely ensure protein expression upon 
further behavioral testing (e.g., social exploration) on the same day of the ISS 
procedure. A variant of FosB is AFosB. AFosB is able to maintain protein 
expression on a longer basis. Depending on the particular protein of AFosB, it 
can have a half-life at 28 h (Fos-related antigen-1) or 208 h (Fos-related antigen- 
2) in response to repeated stimuli (Kovacs, 1998). Utilizing FosB or AFosB as a 
neural marker may appear to be a favorable option in assessing stress- or 
anxiety-related models that have larger gaps of time between testing in our 
laboratory for subsequent studies.
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Conclusion
Overall, the experiments discussed provided further insight to the ISS 
paradigm. These experiments revealed the first behavioral ISS-induced deficit 
associated with an anxiety behavior (i.e., SE reduction), which supports the 
trans-situational value of our stressor. The experiments also validated the ISS 
model as an animal model of depression appropriate for examining the common 
comorbidity of anxiety and depression for people suffering from major depression 
(Wheeler, Blankstein, Antony, McCabe, & Bieling, 2011); and also suggests that 
the ISS paradigm is a model for post-traumatic stress disorder. As our laboratory 
has not previously investigated cellular mechanisms, the first experiment 
provided an enlightening initial step for subsequent experiments. It is now known 
that distinguishable c-Fos expression is not as readily present approximately 24h 
following exposure to ISS. As a result, future immunohistochemistry experiments 
must carefully assess the time course of various Fos proteins.
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